Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism

Molecular and Cellular Biology

Volumn 32, Issue 24, 2012, Pages 5103-5115

  Farjo, Krysten M ^a   Farjo, Rafal A ^b   Halsey, Stacey ^a   Moiseyev, Gennadiy ^a   Ma, Jian xing ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b EyeCRO LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RETINOL; RETINOL BINDING PROTEIN 4; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CARDIOVASCULAR DISEASE; CELL ADHESION; DISEASE COURSE; IMMUNOCYTOCHEMISTRY; INFLAMMATION; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA CAPILLARY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL;

BASE SEQUENCE; CELLS, CULTURED; CHEMOKINE CCL2; DNA, COMPLEMENTARY; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; NADPH OXIDASE; NF-KAPPA B; RECOMBINANT PROTEINS; RETINAL VESSELS; RETINOL-BINDING PROTEINS, PLASMA; VASCULAR CELL ADHESION MOLECULE-1; VITAMIN A;

EID: 84871867509     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00820-12     Document Type: Article

References (66)

1. Aeberli I, et al. 2007. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J. Clin. Endocrinol. Metab. 92:4359- 4365.
2. Al-Shabrawey M, et al. 2005. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am. J. Pathol. 167:599-607.
3. Al-Shabrawey M, et al. 2008. Role of NADPH oxidase in retinal vascular inflammation. Invest. Ophthalmol. Vis. Sci. 49:3239 -3244.
4. Andonegui G, et al. 2009. Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gram-negative bacterial infection. J. Clin. Invest. 119:1921-1930.
5. Balagopal P, et al. 2007. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J. Clin. Endocrinol. Metab. 92:1971-1974.
6. Barazzoni R, et al. 2011. High plasma Rbp4 is associated with systemic inflammation independently of low Rbp4 adipose expression and is normalized by transplantation in non-obese, non-diabetic patients with chronic kidney disease. Clin. Endocrinol. (Oxf.) doi:10.1111/j.1365- 2265.2011.03990.x.
7. Beckman JA, Creager MA, Libby P. 2002. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287:2570 - 2581.
8. Berry DC, Jin H, Majumdar A, Noy N. 2011. Signaling by vitamin A and retinol-binding protein regulates gene expression to inhibit insulin responses. Proc. Natl. Acad. Sci. U. S. A. 108:4340-4345.
9. Blomhoff R, Blomhoff HK. 2006. Overview of retinoid metabolism and function. J. Neurobiol. 66:606-630.
10. Bobbert T, et al. 2010. Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis 213: 549-551.
11. Brand K, et al. 1996. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J. Clin. Invest. 97:1715-1722.
12. Brand K, Page S, Walli AK, Neumeier D, Baeuerle PA. 1997. Role of nuclear factor-kappa B in atherogenesis. Exp. Physiol. 82:297-304.
13. Bremer AA, Devaraj S, Afify A, Jialal I. 2011. Adipose tissue dysregulation in patients with metabolic syndrome. J. Clin. Endocrinol. Metab. 96:E1782-E1788.
14. Caballero AE, et al. 1999. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48:1856 -1862.
15. Cersosimo E, DeFronzo RA. 2006. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab. Res. Rev. 22:423- 436.
16. Chen P, Guo AM, Edwards PA, Trick G, Scicli AG. 2007. Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293:R1619 -R1629.
17. Christensen EI, et al. 1999. Evidence for an essential role of megalin in transepithelial transport of retinol. J. Am. Soc. Nephrol. 10:685- 695.
18. Chun JT, Wang L, Pasinetti GM, Finch CE, Zlokovic BV. 1999. Glycoprotein 330/megalin (LRP-2) has low prevalence as mRNA and protein in brain microvessels and choroid plexus. Exp. Neurol. 157:194 -201.
19. Collins T, et al. 1995. Transcriptional regulation of endothelial cell ad-hesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9:899 -909.
20. Creager MA, Luscher TF, Cosentino F, Beckman JA. 2003. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy. Part I. Circulation 108:1527-1532.
21. Cybulsky MI, et al. 2001. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 107:1255-1262.
22. Deng ZB, et al. 2009. Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes 58:2498 -2505.
23. De Taeye BM, et al. 2007. Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am. J. Physiol. Endocrinol. Metab. 293:E713-E725.
24. Endemann DH, Schiffrin EL. 2004. Endothelial dysfunction. J. Am. Soc. Nephrol. 15:1983-1992.
25. Erikstrup C, et al. 2009. RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes. Diabetes Obes. Metab. 11:204 -212.
26. Fong DS, et al. 2004. Retinopathy in diabetes. Diabetes Care 27(Suppl 1):S84 -S87.
27. Frey RS, Ushio-Fukai M, Malik AB. 2009. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid. Redox Signal. 11:791- 810.
28. Geiger M, Stone A, Mason SN, Oldham KT, Guice KS. 1997. Differential nitric oxide production by microvascular and macrovascular endothelial cells. Am. J. Physiol. 273:L275-L281.
29. Glassberg MK, et al. 1992. Microvascular and macrovascular endothelial cells produce different constrictor substances. J. Appl. Physiol. 72:1681- 1686.
30. Grafe M, et al. 1998. Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL. Atherosclerosis 137:87-95.
31. Graham TE, Wason CJ, Bluher M, Kahn BB. 2007. Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia 50:814-823.
32. Graham TE, et al. 2006. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med. 354:2552-2563.
33. Haider DG, et al. 2007. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J. Clin. Endocrinol. Metab. 92: 1168-1171.
34. Ingelsson E, et al. 2009. Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis 206:239 -244.
35. Jackson CJ, Nguyen M. 1997. Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. Int. J. Biochem. Cell Biol. 29:1167-1177.
36. Kannel WB, McGee DL. 1979. Diabetes and cardiovascular disease. The Framingham study. JAMA 241:2035-2038.
37. Kannel WB, McGee DL. 1979. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 2:120 -126.
38. Kawaguchi R, et al. 2007. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 315:820-825.
39. Kern TS. 2007. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp. Diabetes Res. 2007: 95103. doi:10.2337/db11-1249.
40. Kowalska I, et al. 2008. Serum retinol binding protein 4 is related to insulin resistance and nonoxidative glucose metabolism in lean and obese women with normal glucose tolerance. J. Clin. Endocrinol. Metab. 93: 2786-2789.
41. Li ZZ, Lu XZ, Liu JB, Chen L. 2010. Serum retinol-binding protein 4 levels in patients with diabetic retinopathy. J. Int. Med. Res. 38:95-99.
42. Libermann TA, Baltimore D. 1990. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol. 10:2327-2334.
43. Lim S, et al. 2008. Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women. J. Clin. Endocrinol. Metab. 93:2263-2268.
44. Lu Z, et al. 2012. Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6. Arterioscler. Thromb. Vasc. Biol. 32: 1696-1706.
45. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR. 2007. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56:16 -23.
46. Lumeng CN, Deyoung SM, Saltiel AR. 2007. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am. J. Physiol. Endocrinol. Metab. 292:E166 -E174.
47. Masuyama H, Inoue S, Hiramatsu Y. 2011. Retinol-binding protein 4 and insulin resistance in preeclampsia. Endocr. J. 58:47-53.
48. Mills JP, Furr HC, Tanumihardjo SA. 2008. Retinol to retinol-binding protein (RBP) is low in obese adults due to elevated apo-RBP. Exp. Biol. Med. (Maywood) 233:1255-1261.
49. Moiseyev G, et al. 2006. RPE65 is an iron(II)-dependent isomerohydrolase in the retinoid visual cycle. J. Biol. Chem. 281:2835-2840.
50. Mostafaie N, et al. 2011. Circulating retinol-binding protein 4 and metabolic syndrome in the elderly. Wien. Med. Wochenschr. 161:505-510.
51. Norseen J, et al. 2012. Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism. Mol. Cell. Biol. 32:2010 -2019.
52. Qi Q, et al. 2007. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J. Clin. Endocrinol. Metab. 92:4827- 4834.
53. Ross R. 1999. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340:115-126.
54. Rovin BH, Dickerson JA, Tan LC, Hebert CA. 1995. Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells. Kidney Int. 48:1263-1271.
55. Sasaki M, Otani T, Kawakami M, Ishikawa SE. 2010. Elevation of plasma retinol-binding protein 4 and reduction of plasma adiponectin in subjects with cerebral infarction. Metabolism 59:527-532.
56. Solini A, Santini E, Madec S, Rossi C, Muscelli E. 2009. Retinol-binding protein-4 in women with untreated essential hypertension. Am. J. Hypertens. 22:1001-1006.
57. Stratton IM, et al. 2000. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405- 412.
58. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T. 2007. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J. Clin. Endocrinol. Metab. 92:2712-2719.
59. Ushio-Fukai M. 2006. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc. Res. 71:226 -235.
60. van Hecke MV, et al. 2005. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia 48:1300- 1306.
61. Viemann D, et al. 2006. TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells. J. Leukoc. Biol. 80:174 -185.
62. Violi F, Basili S, Nigro C, Pignatelli P. 2009. Role of NADPH oxidase in atherosclerosis. Future Cardiol. 5:83-92.
63. Xie Y, Lashuel HA, Miroy GJ, Dikler S, Kelly JW. 1998. Recombinant human retinol-binding protein refolding, native disulfide formation, and characterization. Protein Expr. Purif. 14:31-37.
64. Xu H, et al. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112: 1821-1830.
65. Yang Q, et al. 2005. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436:356 -362.
66. Yao-Borengasser A, et al. 2007. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J. Clin. Endocrinol. Metab. 92:2590 -2597.